← Back
Data updated: Mar 10, 2026
SUVEN PHARMS
Pharmaceuticals
SUVEN PHARMS is a generic drug manufacturer with 4 FDA-approved products.
2012
Since
4
Drugs
-
Trials
18
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
GLYCOPYRROLATE 2025-12-23
GLYCOPYRROLATE 2025-10-27
GLYCOPYRROLATE 2025-09-17
Labeling
GLYCOPYRROLATE 2025-08-11
Labeling
GLYCOPYRROLATE 2025-07-16
Efficacy
GLYCOPYRROLATE 2025-06-26
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 2012-05-23
- Latest
- 2023-07-24
- Applications
- 4